Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gastroparesis: clinical update.

Moo-In Park1, Michael Camilleri

  • 1Department of Internal Medicine, College of Medicine, Kosin University, Busan, Korea.

The American Journal of Gastroenterology
|May 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gastrointestinal motility disorders in neurologic disease.

The Journal of clinical investigation·2021
Same author

Relationship of motor mechanisms to gastroparesis symptoms: toward individualized treatment.

American journal of physiology. Gastrointestinal and liver physiology·2021
Same author

Liraglutide reduces attenuation coefficient as a measure of hepatic steatosis during 16 weeks' treatment in nondiabetic obese patients: A pilot trial.

JGH open : an open access journal of gastroenterology and hepatology·2021
Same author

Human Intestinal Barrier: Effects of Stressors, Diet, Prebiotics, and Probiotics.

Clinical and translational gastroenterology·2021
Same author

Every Breath Test You Take: Practical Advice on Breath Testing Used to Detect Small Intestinal Bacterial Overgrowth.

Digestive diseases and sciences·2021
Same author

International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.

Pharmacological reviews·2020

Gastroparesis, a condition of abnormal gastric motility, presents challenges in management, especially in severe cases. Recent therapeutic advances offer new hope for patients with refractory gastroparesis.

Area of Science:

  • Gastroenterology
  • Clinical Medicine

Background:

  • Gastroparesis is characterized by delayed gastric emptying without mechanical obstruction.
  • It can be idiopathic or linked to conditions like diabetes mellitus, post-surgery, infections, or scleroderma.
  • Management strategies include diet, prokinetics, and surgery, with severe cases often requiring specialist care.

Purpose of the Study:

  • To critically review recent advances in managing gastroparesis.
  • To highlight new therapeutic options for refractory cases.

Main Methods:

  • Literature review of recent advancements in gastroparesis treatment.
  • Clinical perspective on novel therapies.

Main Results:

  • Established treatments are effective for mild gastroparesis.

Related Experiment Videos

  • Severe and refractory gastroparesis remains challenging.
  • Emerging therapies like new drugs, botulinum toxin, and gastric electrical stimulation show promise.

    • Conclusions:

    • Advances in drug therapy, botulinum toxin injection, and gastric electrical stimulation offer potential new hope for patients with refractory gastroparesis.
    • Clinicians should be aware of these emerging treatment modalities.